CAR-macrophage therapy alleviates myocardial ischemia-reperfusion injury (undamage)
Male C57BL/6J mice, aged between eight to ten weeks were intravenously administered CAR-Ms/BMDMs/PBS. Transcriptional profiling was conducted on the hearts of mice 11 days after injection with CAR-Ms/BMDMs/PBS.